Furthermore, previous studies have reported that silencing of Orai1 and Orai2 expression attenuate the Akt/mammalian target of rapamycin/NF-κB pathway in oral cancer cells, further supporting a role for Orai channels in NF-κB activation (29). The gene discussed is AKT1; the disease is lip and oral cavity carcinoma.